Phase 3 Endometrial Cancer Trial, Recruiting (NCT04733820)

Phase 3 Endometrial Cancer Trial, Recruiting NCT04733820 Sponsor: Huazhong University of Science and Technology Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04733820 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with cervical cancer at a specific stage (stage IB3 to IIB, based on 2018 guidelines) and your tumor was larger than 4cm before any treatment began.
Your cervical cancer has been confirmed by a lab test (biopsy), and it is one of these types: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma.
You are between 18 and 70 years old.
You are generally active and able to carry out daily activities with little or no limitation (confirm with trial site).
Your blood counts, liver function, and kidney function are all within acceptable ranges as measured by blood tests (confirm with trial site for specific values).
You are willing and able to follow the trial's instructions and stay in contact with the trial team.
You are able to read, understand, and sign a consent form agreeing to take part in the trial.

Who may not be able to join:

You did not have a specific type of surgery (open or keyhole radical hysterectomy with lymph node removal, using a particular surgical technique) after 2–3 rounds of pre-surgery chemotherapy.
The chemotherapy used before surgery was different from the chemotherapy planned after surgery.
After surgery, it was found that cancer had spread to lymph nodes, surrounding tissues near the uterus, or that cancer cells were found at the edges of the removed tissue.
After surgery, certain other moderate risk factors were identified that meet specific medical guidelines (confirm with trial site).
You are currently taking part in another clinical trial.
You have serious health conditions affecting other major organs or body systems.
You are not legally able to make your own medical decisions.
You have a current problem with drug and/or alcohol misuse.
You are unwilling or unable to sign a consent form.
The trial researchers decide for any other reason that you are not suitable for the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 0086-27-83662681

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04733820

Sponsor: Huazhong University of Science and Technology

Phase: Phase 3

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: 0086-27-83662681

More information: https://clinicaltrials.gov/study/NCT04733820

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with cervical cancer at a specific stage (stage IB3 to IIB, based on 2018 guidelines) and your tumor was larger than 4cm before any treatment began.
Your cervical cancer has been confirmed by a lab test (biopsy), and it is one of these types: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma.
You are between 18 and 70 years old.
You are generally active and able to carry out daily activities with little or no limitation (confirm with trial site).
Your blood counts, liver function, and kidney function are all within acceptable ranges as measured by blood tests (confirm with trial site for specific values).
You are willing and able to follow the trial's instructions and stay in contact with the trial team.
You are able to read, understand, and sign a consent form agreeing to take part in the trial.

Who may not be able to join:

You did not have a specific type of surgery (open or keyhole radical hysterectomy with lymph node removal, using a particular surgical technique) after 2–3 rounds of pre-surgery chemotherapy.
The chemotherapy used before surgery was different from the chemotherapy planned after surgery.
After surgery, it was found that cancer had spread to lymph nodes, surrounding tissues near the uterus, or that cancer cells were found at the edges of the removed tissue.
After surgery, certain other moderate risk factors were identified that meet specific medical guidelines (confirm with trial site).
You are currently taking part in another clinical trial.
You have serious health conditions affecting other major organs or body systems.
You are not legally able to make your own medical decisions.
You have a current problem with drug and/or alcohol misuse.
You are unwilling or unable to sign a consent form.
The trial researchers decide for any other reason that you are not suitable for the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Huazhong University of Science and Technology

Registry

ClinicalTrials.gov

Start date

1 February 2021

Est. completion

1 February 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease-free survival (DFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov